Response to Comments: MolDX: Repeat Germline Testing

This document is a response-to-comments notice regarding MolDX Repeat Germline Testing (LCD L38351) and provides procedural dates: comment period 2019-10-22 to 2019-12-06, notice 2020-06-18, and effective date 2020-08-03. The provided excerpt contains no clinical coverage criteria, indications, limitations, or frequency rules; manual review of the full LCD is required to extract clinical policy details.

"Notice and effective dates for LCD L38351: comment period began 2019-10-22 and ended 2019-12-06; notice period begins 2020-06-18 and LCD becomes effective 2020-08-03."

Sign up to see full coverage criteria, indications, and limitations.